Form 4 holding
Director
Protalix BioTherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 7,500
- Estimated value
- $12,075
- Report date
- 03 Sep 2025
- Price
- $1.61
- Ownership
- By Trust
Gwen A. Melincoff - Director at Protalix BioTherapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- PLX on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Gwen A. Melincoff since 03 Sep 2025
Reported holdings for Gwen A. Melincoff in Protalix BioTherapeutics, Inc.
Form 4 holding
Director
Protalix BioTherapeutics, Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 15,000
- Estimated value
- Report date
- 03 Sep 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Gwen A. Melincoff in Protalix BioTherapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.